Company: NGVT
Filing Date: 2025-03-10
Form Type: PREC14A
Source: 0001308179-25-000061
Chunk: 18

Company: Ingevity Corp
Filing Date: 2025-03-10
Form: PREC14A
Chunk 18
---
, with the assistance of the Nominating & Governance Committee, annually (or more frequently if circumstances require) assesses the independence of each director.

| INGEVITY  |  2025 
 Proxy Statement   | 33 |

Board and Corporate Governance Matters Evaluating Board performance and effectiveness In conducting its independence assessment, the Board reviews all relevant facts and circumstances, including each nominee’s affiliations and relationships, potential conflicts of interest, and all specific criteria included in the NYSE’s general listing standards. An independent director is a director who our Board affirmatively determines has no material relationship with the Company (either directly or as a partner, stockholder, or officer of an organization that has a relationship with the Company) other than in connection with his or her role as a director. In February 2025, the Nominating & Governance Committee and Board conducted their review of each nominee’s affiliations that are relevant to independence. These affiliations were provided by the nominees in their responses to D&O questionnaires distributed by the Company in December 2024. Once the Company received the list of affiliations, it conducted additional diligence on each relationship and ran searches against the Company’s books and records to determine whether any financial transactions existed with the affiliates. Results of the diligence and searches were reported to the Nominating & Governance Committee and the Board. After reviewing the affiliations and report described above, upon the recommendation of the Nominating & Governance Committee, the Board affirmatively determined that all director nominees other than Mr. Fernandez-Moreno (Ingevity’s Interim President and CEO) are independent in accordance with applicable rules and regulations of the SEC and the general listing standards of the NYSE. Evaluating Board performance and effectiveness The Nominating & Governance Committee assists the Board in annually assessing the effectiveness of the Board, its committees, and each director in carrying out their respective roles, as described below.

| Format                                                                                                                              |     | Topics                                               |     | Presentation                                                                                                                     
 of Findings                                                                                                                      |     | Feedback                                                                   
 Incorporated                                                               |
| The Nominating & Governance Committee determines the format of the                                                                  
 evaluations, and annually considers the effectiveness of the evaluation process. Under the current process, each director completes 
 a written questionnaire to provide feedback on various aspects of the Board and the committees on which such director serves, and   
 to provide general feedback on each director. The chair of the Nominating & Governance Committee then reviews each questionnaire    
 with the director who completed it to ensure the feedback given